Get the Stockscreener App
0.8691
6.05%
0.0496
Shattuck Labs Inc stock is traded at $0.8691, with a volume of 230.88K.
It is up +6.05% in the last 24 hours and down -16.03% over the past month.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
See More
Previous Close:
$0.8195
Open:
$0.8054
24h Volume:
230.88K
Relative Volume:
1.00
Market Cap:
$41.63M
Revenue:
$2.72M
Net Income/Loss:
$-85.08M
P/E Ratio:
-0.4503
EPS:
-1.93
Net Cash Flow:
$-70.93M
1W Performance:
+16.66%
1M Performance:
-16.03%
6M Performance:
-25.08%
1Y Performance:
-79.84%
1-Day Range:
$0.8054
$0.9179
1-Week Range:
$0.7399
$0.9179
52-Week Range:
$0.6922
$4.59
Shattuck Labs Inc Stock (STTK) Company Profile
Name
Shattuck Labs Inc
Sector
Industry
Phone
512-900-4690
Address
500 W. 5TH STREET, AUSTIN
Compare STTK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
0.8691 | 39.26M | 2.72M | -85.08M | -70.93M | -1.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-25 | Initiated | Leerink Partners | Outperform |
| Oct-02-24 | Downgrade | Citigroup | Buy → Neutral |
| Oct-02-24 | Downgrade | Needham | Buy → Hold |
| Oct-01-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-17-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-31-22 | Initiated | BTIG Research | Buy |
| Jun-01-22 | Initiated | Citigroup | Buy |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Berenberg | Buy |
| Jan-11-21 | Initiated | Evercore ISI | Outperform |
| Nov-03-20 | Initiated | Citigroup | Buy |
| Nov-03-20 | Initiated | Cowen | Outperform |
| Nov-03-20 | Initiated | Needham | Buy |
View All
Shattuck Labs Inc Stock (STTK) Latest News
What drives Shattuck Labs Inc. stock priceUnmatched profit potential - PrintWeekIndia
Is Shattuck Labs Inc. stock overhyped or has real potentialExceptional trading performance - jammulinksnews.com
Does Shattuck Labs Inc. stock pay reliable dividendsSuperior investment outcomes - jammulinksnews.com
Shattuck Labs Inc. Stock Analysis and ForecastBreakthrough profit margins - jammulinksnews.com
Is Shattuck Labs Inc. a good long term investmentExplosive portfolio gains - Autocar Professional
What analysts say about Shattuck Labs Inc. stockHigh-impact investment strategies - Autocar Professional
SHATTUCK ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Shattuck Labs, Inc. and Encourages Investors to Contact the Firm - Finance Monthly
What drives ALEC stock priceFree Trend-Following Techniques - jammulinksnews.com
OceanPal Inc. Stock Analysis and ForecastTremendous gains - jammulinksnews.com
Shattuck Labs elects directors and ratifies auditor at annual meeting By Investing.com - Investing.com South Africa
Shattuck Labs elects directors and ratifies auditor at annual meeting - Investing.com Australia
Shattuck Labs Elects Directors, Approves Auditor at Meeting - TipRanks
Why Shattuck Labs Inc. stock attracts strong analyst attentionFree Stock Market Forums - Newser
How Shattuck Labs Inc. stock performs during market volatilityPotential Rocket List - Newser
Why La Z Boy Incorporated stock attracts strong analyst attentionFree Discussion Group - Newser
What makes Shattuck Labs Inc. stock price move sharplySafe and Scalable Investment Tips - Newser
Why PLAG stock attracts strong analyst attentionHigh Return Stock Alerts - Newser
What makes VSE Corporation stock price move sharplyFree Stock Selection with 300% Return - Newser
Why TSLX stock attracts strong analyst attentionFree Stock Market Trend Analysis - Newser
What makes Mativ Holdings Inc. stock price move sharplyHigh Yield Stock Selection - Newser
Shattuck Labs CEO to Reveal Latest TL1A Breakthroughs in IBD Treatment at Prestigious Leerink Panel - Stock Titan
Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism - 富途牛牛
Shattuck Labs, Inc. (NASDAQ:STTK) Receives $7.50 Consensus Target Price from Analysts - Defense World
Bank of America Corp DE Raises Stock Position in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Here's Why We're Watching Shattuck Labs' (NASDAQ:STTK) Cash Burn Situation - Yahoo Finance
Millennium Management LLC Sells 34,034 Shares of Braemar Hotels & Resorts (NYSE:BHR) - Defense World
Two Sigma Investments LP Takes $206,000 Position in Avino Silver & Gold Mines Ltd. (NYSE:ASM) - Defense World
Shattuck Labs Inc Stock (STTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.32%
1.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):